HyperRHO S/D Immune Globulin Mini-Dose WHS, 250U (250 MCG) Prefilled Syringes 10/Box

Name: HyperRHO S/D Immune Globulin Mini-Dose WHS, 250U (250 MCG) Prefilled S
Brand: Grifols Therapeutics
SKU: 13533-0661-06
Price: 449.00 USD
Availability: InStock

by Grifols Therapeutics

Save 35%

$ 689.95

$ 449.00

SKU 13533-0661-06

Medical Professional License Required to Unlock Account

(Note: We don’t Fill Personal Prescriptions)

How to Order:

✔ Create an Account by Clicking “Login” on Top Right

✔ Next email a copy of medical License to Sales@mountainside-medical.com

✔ Time: License Approval in Usually Very Fast. Mostly likely 30 to 90 minutes if between Monday to Friday 8 am to 4 pm EST Business Days. Weekends will be approved on Monday.

✔ Once Approved you will receive a Welcome email that your account is approved to purchase RX items.

✔ Login and Start ordering.

✔If you should have any trouble or have a question, Please Call Toll-Free: 1-888-687-4334

✔All RX Deliveries are sent Signature Required

HyperRHO® S/D Mini-Dose (RhO[D] immune globulin [human]) is recommended to prevent the isoimmunization of RhO(D)-negative women at the time of spontaneous or induced abortion of up to 12 weeks' gestation provided the following criteria are met: The mother must be RhO(D) negative and must not already be sensitized to the RhO(D) antigen. The father is not known to be RhO(D) negative. Gestation is not more than 12 weeks at termination.

HyperRHO S/D is an immune globulin with a high level of preformed antibodies against rhesus (Rh)-positive blood cells.
The injection of an RHO(D) immune globulin provides a passive immunity for rapid immune protection and an acute response in high-risk situations.
HyperRHO S/D destroys any Rh-positive blood cells that may have entered the mother's bloodstream and prevents the mother's immune system from producing Rh-positive antibodies, thus protecting the baby from developing hemolytic disease.

Each single-dose syringe of HyperRHO S/D contains sufficient anti-RhO(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells.

Antepartum and postpartum administration of a single dose of HyperRHO S/D to susceptible Rh-negative women reduces the incidence of Rh isoimmunization to less than 0.1%.

Effective Protection
HyperRHO S/D destroys Rh-positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN.